Lv31
248 积分 2023-09-15 加入
Efficacy and safety of Qianlieshutong Capsules in the treatment for Type Ⅲ prostatitis: a post-marketing, multicenter, randomized, double-blind, single-dummy, active-controlled, parallel-group clinical trial
8小时前
待确认
The dawn of spatial omics
2个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
3个月前
已完结
HDAC inhibitor GCJ-490A modulates tumor microenvironment and synergizes with PD-1 antibody against breast and lung cancers in syngeneic murine models
4个月前
已完结
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy
4个月前
已完结
The next generation of immunotherapies for lung cancers
4个月前
已完结
Biomaterials tools to modulate the tumour microenvironment in immunotherapy
4个月前
已完结
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
5个月前
已完结
Harnessing cytokines and chemokines for cancer therapy
5个月前
已完结
TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages
5个月前
已完结
皖公网安备34019202002308
